Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 15/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8307041 | 0.90 | TBXAS1 (0.49) | TBXAS1P2RX3CYP4F2CYP4A11 | |
| SCHEMBL8305260 | 0.88 | TBXAS1 (0.48) | TBXAS1P2RX3CYP4F2CYP4A11 | |
| SCHEMBL8707244 | 0.87 | TBXAS1 (0.46) | TBXAS1P2RX3CYP4F2CYP4A11 | |
| SCHEMBL8707246 | 0.85 | TBXAS1 (0.46) | TBXAS1FFAR1P2RX3CYP4F2CYP4A11 | |
| SCHEMBL10663180 | 0.84 | CYP4F2 (0.54) | TBXAS1FFAR1P2RX3CYP4F2CYP4A11 | |
| SCHEMBL8307393 | 0.84 | TBXAS1 (0.62) | TBXAS1 | |
| SCHEMBL8309271 | 0.83 | TBXAS1 (0.79) | TBXAS1 | |
| SCHEMBL8308674 | 0.82 | TBXAS1 (0.49) | TBXAS1P2RX3 | |
| SCHEMBL8306671 | 0.79 | TBXAS1 (0.79) | TBXAS1 | |
| SCHEMBL8304782 | 0.79 | TBXAS1 (0.46) | TBXAS1FFAR1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579618-B1 | PYRIDINE- AND IMIDAZOLE-DERIVED AGENTS FOR CARDIOVASCULAR DISEASES | PFIZER LTD (GB) | 1999-10-13 | — | — | EP | disclosed |
| US-5705523-A | THROMBOXANE A2 SYNTHETASE INHIBITORS | PFIZER INC. (US) | 1998-01-06 | — | — | US | disclosed |
| US-5457118-A | Pyridine derived agents for cardiovascular diseases | PFIZER INC. (US) | 1995-10-10 | — | — | US | disclosed |
| EP-0579618-A1 | PYRIDINE- AND IMIDAZOLE-DERIVED AGENTS FOR CARDIOVASCULAR DISEASES | Pfizer Limited (GB) | 1994-01-26 | — | — | EP | disclosed |
| WO-1992017451-A1 | PYRIDINE- AND IMIDAZOLE-DERIVED AGENTS FOR CARDIOVASCULAR DISEASES | PFIZER LIMITED (GB) | 1992-10-15 | — | — | WO | disclosed |